Australia – Novavax Dashboard Review (March 29th 2022)
Let’s review the Novavax dashboard by the Australian Therapeutic Goods Administration (TGA).
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
Want to support this work?:
Buy me a coffee 🙂 https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
We will go live on this channel today:
#drbeen #koolbeens #COVID
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Tuesday, Mar. 29 2022
COVID-19 vaccine weekly safety report – 17-03-2022 | Therapeutic Goods Administration (TGA)
Novavax COVID-19 vaccine | AusVaxSafety
Pfizer COVID-19 vaccine adult formulation | AusVaxSafety
Pfizer COVID-19 vaccine paediatric formulation (5-11 years) | AusVaxSafety
Moderna COVID-19 vaccine | AusVaxSafety
AstraZeneca COVID-19 vaccine | AusVaxSafety
TGA provisionally approves Biocelect Pty Ltd’s (on behalf of Novavax Inc) COVID-19 vaccine NUVAXOVID | Therapeutic Goods Administration (TGA)
Product Information: Nuvaxovid (SARS-COV-2 RS [NVX-COV2373]
Consumer Medicine Information: NUVAXOVID COVID-19 VACCINE (adjuvanted)
Nuvaxovid | Therapeutic Goods Administration (TGA)
AusPAR: SARS-CoV-2 rS with Matrix-M adjuvant | Therapeutic Goods Administration (TGA)
COVID-19 vaccine approval process | Therapeutic Goods Administration (TGA)
Database of Adverse Event Notifications